Boston Trust Walden’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $914K | Buy |
7,732
+210
| +3% | +$24.2K | 0.01% | 299 |
|
|
2026
Q1 | $899K | Sell |
7,522
-20
| -0.3% | -$2.62K | 0.01% | 292 |
|
|
2025
Q4 | $1.03M | Buy |
7,542
+3,810
| +102% | +$548K | 0.01% | 276 |
|
|
2025
Q3 | $550K | Buy |
3,732
+30
| +0.8% | +$4.16K | ﹤0.01% | 323 |
|
|
2025
Q2 | $479K | Sell |
3,702
-16
| -0.4% | -$1.94K | ﹤0.01% | 321 |
|
|
2025
Q1 | $444K | Buy |
3,718
+300
| +9% | +$37.2K | ﹤0.01% | 321 |
|
|
2024
Q4 | $397K | Hold |
3,418
| – | – | ﹤0.01% | 330 |
|
|
2024
Q3 | $462K | Hold |
3,418
| – | – | ﹤0.01% | 322 |
|
|
2024
Q2 | $464K | Hold |
3,418
| – | – | ﹤0.01% | 325 |
|
|
2024
Q1 | $442K | Hold |
3,418
| – | – | ﹤0.01% | 327 |
|
|
2023
Q4 | $391K | Buy |
3,418
+107
| +3% | +$10.7K | ﹤0.01% | 322 |
|
|
2023
Q3 | $301K | Hold |
3,311
| – | – | ﹤0.01% | 334 |
|
|
2023
Q2 | $373K | Hold |
3,311
| – | – | ﹤0.01% | 326 |
|
|
2023
Q1 | $347K | Hold |
3,311
| – | – | ﹤0.01% | 330 |
|
|
2022
Q4 | $366K | Hold |
3,311
| – | – | ﹤0.01% | 327 |
|
|
2022
Q3 | $289K | Hold |
3,311
| – | – | ﹤0.01% | 329 |
|
|
2022
Q2 | $259K | Hold |
3,311
| – | – | ﹤0.01% | 344 |
|
|
2022
Q1 | $282K | Hold |
3,311
| – | – | ﹤0.01% | 355 |
|
|
2021
Q4 | $397K | Buy |
3,311
+295
| +10% | +$36.6K | ﹤0.01% | 345 |
|
|
2021
Q3 | $373K | Hold |
3,016
| – | – | ﹤0.01% | 339 |
|
|
2021
Q2 | $362K | Hold |
3,016
| – | – | ﹤0.01% | 344 |
|
|
2021
Q1 | $317K | Hold |
3,016
| – | – | ﹤0.01% | 341 |
|
|
2020
Q4 | $307K | Hold |
3,016
| – | – | ﹤0.01% | 346 |
|
|
2020
Q3 | $254K | Buy |
+3,016
| New | +$235K | ﹤0.01% | 350 |
|
|
2020
Q1 | – | Sell |
-3,016
| Closed | -$238K | – | 382 |
|
|
2019
Q4 | $238K | Hold |
3,016
| – | – | ﹤0.01% | 367 |
|
|
2019
Q3 | $240K | Hold |
3,016
| – | – | ﹤0.01% | 365 |
|
|
2019
Q2 | $252K | Hold |
3,016
| – | – | ﹤0.01% | 362 |
|
|
2019
Q1 | $238K | Hold |
3,016
| – | – | ﹤0.01% | 363 |
|
|
2018
Q4 | $201K | Hold |
3,016
| – | – | ﹤0.01% | 369 |
|
|
2018
Q3 | $241K | Hold |
3,016
| – | – | ﹤0.01% | 364 |
|
|
2018
Q2 | $203K | Hold |
3,016
| – | – | ﹤0.01% | 373 |
|
|
2018
Q1 | $232K | Hold |
3,016
| – | – | ﹤0.01% | 372 |
|
|
2017
Q4 | $206K | Buy |
+3,016
| New | +$200K | ﹤0.01% | 378 |
|
Other funds holding XYL
Boston Trust Walden's XYL Position: Q2 2026 in Review
Boston Trust Walden increased its Xylem (XYL) stake by 2.8% in Q2 2026, buying an estimated $24.2K and bringing the position to 7,732 shares worth $914K. The position accounts for 0.01% of the portfolio, ranked #299.
Boston Trust Walden first reported a position in XYL in Q4 2017 and has held it in 33 quarters since. The position peaked at $1.03M in Q4 2025. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- Boston Trust Walden held 7,732 shares of Xylem worth $914K as of Q2 2026.
- Boston Trust Walden bought 210 Xylem shares in Q2 2026, an estimated $24.2K.
- Xylem made up 0.01% of Boston Trust Walden's portfolio in Q2 2026, its #299 holding.
- Boston Trust Walden first reported a position in Xylem in Q4 2017 and has held it in 33 quarters since.
- Boston Trust Walden's Xylem position peaked at $1.03M in Q4 2025.
- 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.